TransMedics Group, Inc. TMDX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Heart Product | $127.06M+0.8% | $126.01M+1.4% | $124.21M+3.0% | $120.55M+3.6% | $116.32M+5.9% | |
| Liver Product | $490.65M+6.5% | $460.53M+9.2% | $421.89M+8.0% | $390.62M+11.1% | $351.55M+13.5% | |
| Lung Product | $13.67M-8.0% | $14.86M-7.8% | $16.11M+1.3% | $15.91M-0.7% | $16.03M-9.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does TransMedics Group, Inc. break its business down?
- TransMedics Group, Inc. (TMDX) reports revenue by product across 3 parts — Heart Product, Liver Product and Lung Product. Each is extracted from the segment footnotes and tracked over time.
- Where does TransMedics Group, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in TransMedics Group, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
